Updates in the pathogenesis of SJS/TEN
Allergology International · 2025-07 · 74 (3) · 361-371
DOI: 10.1016/j.alit.2025.05.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Allergology International, 2025-07. Verfasst von Joy Justice und 3 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt University School of Medicine, Nashville, TN, USA. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NHGRI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions across a spectrum of severity characterized by widespread epidermal detachment and keratinocyte apoptosis. SJS/TEN develops due to a complex immunologic response after exposure to an associated drug antigen and/or its metabolite, and it results in significant morbidity and mortality. Complex immune mechanisms contribute to keratinocyte death. Drug-induced SJS/TEN has been shown to be strongly HLA class I restricted which has contributed to our understanding of mechanisms and has the potential to shape prevention and diagnosis. There is currently no evidence-based treatment outside of aggressive supportive care, and understanding the complete immunopathogenesis of SJS/TEN will be key for the development of efficacious and safe treatments that significantly reduce morbidity and mortality. This article focuses on what is new in the pathogenesis of SJS/TEN, including recent research on the mechanisms of T-cell activation, apoptotic and necroptotic mediators, other related molecules, genetic associations, and possible targeted treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vanderbilt University School of Medicine, Nashville, TN, USA.
- Vanderbilt University Medical Center, Department of Dermatology, Nashville, TN, USA; Vanderbilt University Medical Center, Center for Drug Safety and Immunology, Nashville, TN, USA.
- Vanderbilt University Medical Center, Center for Drug Safety and Immunology, Nashville, TN, USA.
- Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Nashville, TN, USA. Electronic address: elizabeth.j.phillips@vumc.org.
Förderung
- NIAMS NIH HHS
- NHGRI NIH HHS
- NIAID NIH HHS
- National Health and Medical Research Council
- NIH NIAID
- National Institutes of Health
Zitieren
APA
Justice, J., Mukherjee, E., Martin-Pozo, M., & Phillips, E. (2025). Updates in the pathogenesis of SJS/TEN. Allergology International, 74(3), 361-371. https://doi.org/10.1016/j.alit.2025.05.002
Vancouver
Justice J, Mukherjee E, Martin-Pozo M, Phillips E. Updates in the pathogenesis of SJS/TEN. Allergology International. 2025;74(3):361-371. doi:10.1016/j.alit.2025.05.002
BibTeX
@article{Justice2025,
author = {Justice, Joy and Mukherjee, Eric and Martin-Pozo, Michelle and Phillips, Elizabeth},
title = {Updates in the pathogenesis of SJS/TEN},
journal = {Allergology International},
year = {2025},
volume = {74},
number = {3},
pages = {361--371},
doi = {10.1016/j.alit.2025.05.002}
}
EUVIMED